Quality control on fissure treatment of flood release dam section of TGP stage II works

被引：0
|
作者：
Du, Ze-Kuai
Zheng, Lu
机构：
来源：
Renmin Changjiang/Yangtze River | 2002年 / 33卷 / 10期
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 49 条
  • [31] Microcystis aeruginosa-laden water treatment using enhanced coagulation by calcium peroxide/Fe(II): Simultaneously enhanced algae removal, controlled AOM release and improved water quality
    Xin, Huaijia
    Tang, Yulin
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2018, 256
  • [32] Quality Control by Photo Documentation for Evaluation of Laparoscopic and Open Colectomy with D3 Resection for Stage II/III Colorectal Cancer: Japan Clinical Oncology Group Study JCOG 0404
    Nakajima, Kentaro
    Inomata, Masafumi
    Akagi, Tomonori
    Etoh, Tsuyoshi
    Sugihara, Kenichi
    Watanabe, Masahiko
    Yamamoto, Seiichiro
    Katayama, Hiroshi
    Moriya, Yoshihiro
    Kitano, Seigo
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2014, 44 (09) : 799 - 806
  • [33] CLINICAL-FEATURES AND TREATMENT OF TYPE-II, TYPE-III AND TYPE-IV FRACTURES OF THE MID-SECTION OF THE CARPAL NAVICULAR BONE - PSEUDARTHROSIS WITH A LIVING PROXIMAL FRAGMENT - RESULTS OF TREATMENT FOR STAGE-I PSEUDARTHROSIS OF THE CARPAL NAVICULAR BONE
    SAILLANT, G
    LAZENNEC, JY
    ROYCAMILLE, R
    REVUE DE CHIRURGIE ORTHOPEDIQUE ET REPARATRICE DE L APPAREIL MOTEUR, 1988, 74 (08): : 727 - 728
  • [34] Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial
    Qasir Abbas
    Sana Latif
    Hina Ayaz Habib
    Salman Shahzad
    Uzma Sarwar
    Mafia Shahzadi
    Zoobia Ramzan
    Washdev Washdev
    BMC Psychiatry, 23
  • [35] Cognitive behavior therapy for diabetes distress, depression, health anxiety, quality of life and treatment adherence among patients with type-II diabetes mellitus: a randomized control trial
    Abbas, Qasir
    Latif, Sana
    Habib, Hina Ayaz
    Shahzad, Salman
    Sarwar, Uzma
    Shahzadi, Mafia
    Ramzan, Zoobia
    Washdev, Washdev
    BMC PSYCHIATRY, 2023, 23 (01)
  • [36] Quality of life in survivors of stage I-II breast cancer, 10 years outcome of a randomized clinical trial comparing post-operative hypofractionation with Tomotherapy versus conventional radiation treatment (TomoBreast)
    Van Parijs, Hilde
    Vinh-Hung, Vincent
    Fontaine, Christel
    Storme, Guy A.
    Adriaenssens, Nele
    Hanon, Shane
    Vanhoeij, Marian
    Lustberg, Maryam B.
    Williams, Nicole
    Nguyen, Dung M.
    Nguyen, Nam P.
    Verschraegen, Claire
    De Ridder, Mark
    CANCER RESEARCH, 2020, 80 (04)
  • [37] Carboplatin and irinotecan (CI) vs. carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial
    Shimokawa, Tsuneo
    Okamoto, Hiroaki
    Machida, Ryunosuke
    Misumi, Yuki
    Hosomi, Yukio
    Yoneshima, Yasuto
    Tanaka, Hiroshi
    Okishio, Kyoichi
    Simizu, Junichi
    Goto, Koichi
    Akamatsu, Hiroaki
    Kubota, Kaoru
    Nakagawa, Kazuhiko
    Horinouchi, Hidehito
    Ando, Masahiko
    Kataoka, Tomoko
    Ohe, Yuichiro
    LUNG CANCER, 2023, 181
  • [38] A multicentre, double blind, randomised, placebo controlled, Phase II trial to evaluate Resminostat for maintenance treatment of patients with advanced stage (Stage IIB - IVB) mycosis fungoides (MF) or Sezary Syndrome (SS) that have achieved disease control with systemic therapy - the RESMAIN Study
    Stadler, R.
    Scarisbrick, J.
    Knobler, R.
    Quaglino, P.
    Borgmann, M.
    Orlovius, M.
    Krauss, B.
    Danhauser-Riedl, S.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2017, 31 : 50 - 50
  • [39] Comment on: Carboplatin and irinotecan (CI) vs. Carboplatin and etoposide (CE) for the treatment of extended-stage small-cell lung cancer in an elderly population: A phase II/III randomized control trial
    Furune, Satoshi
    Ando, Yuichi
    LUNG CANCER, 2023, 186
  • [40] A multicenter, double blind, randomized, placebo-controlled, phase II trial to evaluate resminostat for maintenance treatment of patients with advanced stage (stage IIB-IVB) mycosis fungoides (MF) or Sezary syndrome (SS) that have achieved disease control with systemic therapy: the RESMAIN study
    Stadler, R.
    Scarisbrick, J.
    Knobler, R.
    Quaglino, P.
    Borgmann, M.
    Orlovius, M.
    Reimann, P.
    Danhauser-Riedl, S.
    EUROPEAN JOURNAL OF CANCER, 2019, 119 : S32 - S32
12345